Cauda equina neoplasm

Summary

Cauda equina neoplasm (MONDO:0003164) is a cancer. A subtype of nerve root neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	cauda equina neoplasm
Mondo ID	MONDO:0003164
DOID	DOID:4847
NCIT	C5479
SNOMED CT	126963001
UMLS	C1263892
MedGen	220390
Anatomy (UBERON)	UBERON:0012337
Is cancer (heuristic)	yes

Also known as: cauda equina neoplasm (disease) · Cauda equina neoplasms · cauda equina tumor · cauda equina tumour · neoplasm of cauda equina · neoplasm of the Cauda equina · tumor of Cauda equina · tumor of cauda equina · tumor of the Cauda equina · tumour of Cauda equina · tumour of cauda equina · tumour of the Cauda equina

Disease family

This is a subtype of nerve root neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › peripheral nervous system disorder › peripheral nervous system neoplasm › nerve root neoplasm › cauda equina neoplasm

Subtypes (4): cauda equina intradural extramedullary astrocytoma, cauda equina cancer, benign neoplasm of cauda equina, cauda equina neuroendocrine tumor

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.